Clinical Trial Update: A Phase 3 Clinical Study of SHR-A1912 Combined With R-GemOx Versus R-GemOx in Diffuse Large B-cell Lymphoma [Phase 3]

View source ↗

Summary

A Phase 3 trial evaluating SHR-A1912 plus R-GemOx versus R-GemOx in Diffuse Large B-cell Lymphoma is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diffuse Large B-cell Lymphoma

Drugs mentioned

• R-GemOx (rituximab, gemcitabine, oxaliplatin)
• SHR-A1912 (SHR-A1912)

Snippet

Sponsor: Suzhou Suncadia Biopharmaceuticals Co., Ltd. | Conditions: Diffuse Large B-cell Lymphoma | Phase 3 | Status: RECRUITING